the aid library

LIST OPTIONS

Filter

4587

WHO Guide to conducting programme reviews for HIV, viral hepatitis and sexually transmitted infections

World Health Organization WHO (2023) C_WHO

Sound periodic programme reviews provide opportunities for countries to objectively assess progress and take corrective action to sustain or get back on track towards achieving their medium and long-term programme goals. It reflects people’s diverse needs, enables efficient use of health system re... more

Preventing and responding to an HIV-related human rights crisis — Guidance for United Nations agencies and programmes

UNAIDS (2024) CC

This Guidance was developed in response to the increase in HIV-related human rights crises and the shrinking civic space for rights-related responses to HIV in recent years across the world. This do... more

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (939)

View PDF (1811)

Guidelines on Co-trimoxazole prophylaxis for HIV-exposed and HIV-infected infants and children: Practical approaches to implementation and scale up

World Health Organization; UNICEF (2009) C_WHO

Download (633)

View PDF (1502)

Adolescent HIV Care and Treatment: A Training Curriculum for Health Workers . Module 11 Participant

ICAP; CDC; University Teaching Hospital, et al. (2011)

Download (823)

View PDF (2214)

Adolescent HIV Care and Treatment: A Training Curriculum for Health Workers . Module 11 Presentation Manual

ICAP; CDC; University Teaching Hospital, et al. (2011)

Download (419)

View PDF (1001)

National HIV and AIDS Monitoring and Evaluation Plan 2015/2016 - 2019/2020

Uganda AIDS Commission; Ministry of Health, Uganda (2015) C1

Download (815)

View PDF (939)

Guidelines on the public health response to pretreatment HIV drug resistance

A. Lycett; D. Breuer; F. Verde; et al. World Health Organization (2017) C_WHO

Guidelines HIV drug resistance July 2017

Download (110)

View PDF (157)

Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV - Policy Brief

World Health Organization (2018) C_WHO

HIV Treatment - Interim Guidance

Download (134)

View PDF (298)

HIV-related Stigma and Discrimination and Human Rights in Papua new Guinea

Dr. J. Rule; D. Liriope National Association of People With HIV Australia; IGAT Hope INC.; UNAIDS; et al. (2016) C2

A Report on the Application of the HIV Stigma index in the Western highlands and Chimbu provinces

Download (124)

View PDF (151)

Improving HIV outcomes: Framework and Toolkit for south-to-south technical assistance in the PEPFAR gender strategic areas

M. Gutmann; L. Messner, L. Crye USAID; PEPFAR; AIDS Free (Strenghtening High Impact Interventions for a AIDS-free Generation); JSI Research & Training Institute; et al. (2015) C2

Jury 2015

Ferramenta da OMS para implementação de profilaxia pré-exposição (PrEP) oral ao HIV - Módulo 1

Organização Pan-Americana da Saúde; Organização Mundial da Saúde (Américas) Organização Pan-Americana da Saúde; Organização Mundial da Saúde (Américas) (2019) C_WHO

Módulo 1 Clínico Julho de 2017 Módulo 1: Clínico. Este módulo é destinado a profissionais de saúde como médicos, enfermeiros e auxiliares e traz um resumo sobre como prover a PrEP de forma segura e efetiva, abordando vários aspectos: triagem de pessoas com risco substancial de contr... more

Download (138)

View PDF (159)

Kenya Framework for Elimination of Mother-To-Child Transmissionof HIV and Syphilis 2016-2021

Ministry of Health, Kenya; National AIDS Control Council (2016) C1

HIV drug resistance strategy, 2021 update

World Health Organization WHO (2021) C_WHO

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief
recommended

World Health Organization WHO (2022) C_WHO

Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is respon... more